Immunoglobulin allotypes are not involved in systemic amyloidosis

Area of Science:

• Immunogenetics
• Rheumatology
• Clinical Immunology

Background:

• Immunoglobulin (Ig) allotypes are genetic variants of antibodies.
• Amyloidosis encompasses a group of diseases characterized by protein misfolding and deposition.
• The potential link between specific Ig allotypes and the pathogenesis of different amyloidosis subtypes (AL and AA) requires investigation.

Purpose of the Study:

• To investigate the association between specific immunoglobulin (Ig) allotypes (8 Gm and Km 1) and the development of amyloidosis (AL and AA types).
• To explore the potential role of Ig allotypes in the pathogenesis of amyloidosis.
• To examine the association of the Km 1 allotypic marker with rheumatoid arthritis (RA).

Main Methods:

• Serum samples were collected from patients with amyloid AL (n=27) and AA (n=43) amyloidosis.
• Immunoglobulin (Ig) allotypes, specifically 8 Gm and Km 1, were determined using serological methods.
• Control groups included healthy individuals (n=204), multiple myeloma patients (n=40), rheumatoid arthritis patients (n=71), and Crohn's disease patients (n=47).

Main Results:

• No significant association was found between the studied Gm and Km 1 allotypes and the development of AL or AA amyloidosis.
• The Km 1 allotypic marker showed a significant association with rheumatoid arthritis (RA).

Conclusions:

• Immunoglobulin (Ig) allotypes are not implicated in the pathogenesis of amyloidosis.
• The Km 1 allotypic marker is associated with rheumatoid arthritis, suggesting a potential immunogenetic link in this condition.